IceCure Medical (ICCM) Liabilities and Shareholders Equity (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $13.3 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity changed N/A year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.8 million (down 32.8% YoY) and the FY2025 annual result came in at $13.9 million, up 10.43% from the prior year.
• Liabilities and Shareholders Equity declined to $13.3 million in Q1 2026 per ICCM's latest filing, from $13.9 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $30.2 million in Q4 2022 and bottomed at $12.6 million in Q4 2024.
• The 5-year median for Liabilities and Shareholders Equity is $13.9 million (2025), against an average of $17.3 million.
• The widest annual swing landed in 2023, when Liabilities and Shareholders Equity tumbled 45.64%; it then gained 10.43% in 2025.
• Tracing ICCM's Liabilities and Shareholders Equity over 5 years: stood at $30.2 million in 2022, then tumbled by 45.64% to $16.4 million in 2023, then slipped by 23.36% to $12.6 million in 2024, then rose by 10.43% to $13.9 million in 2025, then slipped by 4.21% to $13.3 million in 2026.
• Per Business Quant, the three latest ICCM Liabilities and Shareholders Equity figures stand at $13.3 million (Q1 2026), $13.9 million (Q4 2025), and $12.6 million (Q4 2024).

Peer Comparison